These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 10223342)

  • 21. Cowpea mosaic virus as a vaccine carrier of heterologous antigens.
    Brennan FR; Jones TD; Hamilton WD
    Mol Biotechnol; 2001 Jan; 17(1):15-26. PubMed ID: 11280928
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Crystal Structure and Proteomics Analysis of Empty Virus-like Particles of Cowpea Mosaic Virus.
    Huynh NT; Hesketh EL; Saxena P; Meshcheriakova Y; Ku YC; Hoang LT; Johnson JE; Ranson NA; Lomonossoff GP; Reddy VS
    Structure; 2016 Apr; 24(4):567-575. PubMed ID: 27021160
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Potential of chimaeric plant virus particles as novel, stable vaccines.
    Xu F; Jones TD; Rodgers PB
    Dev Biol Stand; 1996; 87():201-5. PubMed ID: 8854018
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sequence data to settle the taxonomic position of bean common mosaic virus and blackeye cowpea mosaic virus isolates.
    Khan JA; Lohuis D; Goldbach R; Dijkstra J
    J Gen Virol; 1993 Oct; 74 ( Pt 10)():2243-9. PubMed ID: 8409946
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Co-expression of the capsid proteins of Cowpea mosaic virus in insect cells leads to the formation of virus-like particles.
    Shanks M; Lomonossoff GP
    J Gen Virol; 2000 Dec; 81(Pt 12):3093-3097. PubMed ID: 11086140
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Glycosylation of the capsid proteins of cowpea mosaic virus: a reinvestigation shows the absence of sugar residues.
    Altmann F; Lomonossoff GP
    J Gen Virol; 2000 Apr; 81(Pt 4):1111-4. PubMed ID: 10725439
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evidence for participation of RNA 1-encoded elicitor in Cowpea mosaic virus-mediated concurrent protection.
    Bruening G; Buzayan JM; Ferreiro C; Lim W
    Virology; 2000 Jan; 266(2):299-309. PubMed ID: 10639316
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The refined crystal structure of cowpea mosaic virus at 2.8 A resolution.
    Lin T; Chen Z; Usha R; Stauffacher CV; Dai JB; Schmidt T; Johnson JE
    Virology; 1999 Dec; 265(1):20-34. PubMed ID: 10603314
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development of cowpea mosaic virus-based vectors for the production of vaccines in plants.
    Cañizares MC; Lomonossoff GP; Nicholson L
    Expert Rev Vaccines; 2005 Oct; 4(5):687-97. PubMed ID: 16221070
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Peptide-controlled access to the interior surface of empty virus nanoparticles.
    Sainsbury F; Saunders K; Aljabali AA; Evans DJ; Lomonossoff GP
    Chembiochem; 2011 Nov; 12(16):2435-40. PubMed ID: 21953809
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The molecular basis of the antigenic cross-reactivity between measles and cowpea mosaic viruses.
    Olszewska W; Steward MW
    Virology; 2003 May; 310(1):183-9. PubMed ID: 12788642
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Novel strategy for inhibiting viral entry by use of a cellular receptor-plant virus chimera.
    Khor IW; Lin T; Langedijk JP; Johnson JE; Manchester M
    J Virol; 2002 May; 76(9):4412-9. PubMed ID: 11932408
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genetic engineering and characterization of Cowpea mosaic virus empty virus-like particles.
    Sainsbury F; Saxena P; Aljabali AA; Saunders K; Evans DJ; Lomonossoff GP
    Methods Mol Biol; 2014; 1108():139-53. PubMed ID: 24243247
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cowpea Mosaic Virus Outperforms Other Members of the Secoviridae as In Situ Vaccine for Cancer Immunotherapy.
    Beiss V; Mao C; Fiering SN; Steinmetz NF
    Mol Pharm; 2022 May; 19(5):1573-1585. PubMed ID: 35333531
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Studies on the movement of cowpea mosaic virus using the jellyfish green fluorescent protein.
    Verver J; Wellink J; Van Lent J; Gopinath K; Van Kammen A
    Virology; 1998 Mar; 242(1):22-7. PubMed ID: 9501035
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chimeric animal and plant viruses expressing epitopes of outer membrane protein F as a combined vaccine against Pseudomonas aeruginosa lung infection.
    Gilleland HE; Gilleland LB; Staczek J; Harty RN; García-Sastre A; Palese P; Brennan FR; Hamilton WD; Bendahmane M; Beachy RN
    FEMS Immunol Med Microbiol; 2000 Apr; 27(4):291-7. PubMed ID: 10727884
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The coat protein genes of squash mosaic virus: cloning, sequence analysis, and expression in tobacco protoplasts.
    Hu JS; Pang SZ; Nagpala PG; Siemieniak DR; Slightom JL; Gonsalves D
    Arch Virol; 1993; 130(1-2):17-31. PubMed ID: 8503782
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Amino acids at the exposed C-terminus of the S coat protein of cowpea mosaic virus play different roles in particle formation and viral systemic movement.
    Meshcheriakova Y; Lomonossoff GP
    J Gen Virol; 2019 Jul; 100(7):1165-1170. PubMed ID: 31169482
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficient generation of cowpea mosaic virus empty virus-like particles by the proteolytic processing of precursors in insect cells and plants.
    Saunders K; Sainsbury F; Lomonossoff GP
    Virology; 2009 Oct; 393(2):329-37. PubMed ID: 19733890
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Design and construction of rhinovirus chimeras incorporating immunogens from polio, influenza, and human immunodeficiency viruses.
    Arnold GF; Resnick DA; Li Y; Zhang A; Smith AD; Geisler SC; Jacobo-Molina A; Lee W; Webster RG; Arnold E
    Virology; 1994 Feb; 198(2):703-8. PubMed ID: 7507283
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.